Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *
The DOI matches its Crossref record.
Abstract
To test the effect of opiate receptor blockade on hormone release in man, we administered 10 mg naloxone iv to eight normal subjects and compared the results with those found after saline infusion. Naloxone produced a rise in serum cortisol (P < 0.01), LH (P < 0.01), FSH (P < 0.05), and insulin (P < 0.05) levels but did not alter serum GH, PRL, TSH, arginine vasopressin, glucagon, T3, or T4. Naloxon e had no effect on GH levels in two subjects with active acromegaly or on TSH levels i n six subjects with primary hypothyroidism. In dynamic pituitary function testing, naloxone diminished the GH response to arginine (P < 0.05) without altering the PRL response; naloxone augmented the PRL response to TRH (P < 0.025) without affecting the TSH response. Naloxone did not significantly alter GH or PRL response to L-dopa. Naloxone enhanced the increment in serum cortisol induced by the stress of gastroscopy without changing the GH or PRL response. Naloxone increased glucose response areas (P < 0.05) after an iv glucose bolus and raised the maximum plasma glucose level (P < 0.05) without altering the rate of glucose disappearance. Glucagon and insulin responses to glucose and arginine were not altered by naloxone. Psychological testing showed that naloxone altered performance on the Graham-Kendall Memory for Designs test in half of the subjects studied. There were no significant differences between saline and naloxone trials on the Profile of Mood States questionnaire or the mood-anxiety scale. Together with subjective reports from two of the subjects that naloxone decreased their ability to concentrate, these data suggest that opiate receptors may play a role in short term memory. Specific opiate receptor blockade with naloxone has definite endocrine and metabolic effects, suggesting endogenous opioid modulation of secretion of some of these hormones. Since these effects of naloxone are not always complementary to those of opiates, exogenous opiates may also act on separate receptors which are not blocked by naloxone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
Whitnall, M. H. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90035-q · Cited by 582
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
“Two studies which found that naloxone did not affect PRL levels studied both men and women together and used small numbers of subjects (127, 128).”
Morley, J. E., Levine, A. S., Yim, G. K., & Lowy, M. T. (1983) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(83)90020-9 · Cited by 451
Self-citationAnand, K. J. S., & Carr, D. B. (1989) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36722-0 · Cited by 383
The endocrinology of the opiates and opioid peptides
Morley, J. E. (1981) · Metabolism · doi:10.1016/0026-0495(81)90172-4 · Cited by 283
Self-citation
Metadata
- Authors
- MORLEY, J. E., BARANETSKY, N. G., WINGERT, T. D., CARLSON, H. E., HERSHMAN, J. M., MELMED, S., LEVIN, S. R., JAMISON, K. R., WEITZMAN, R., CHANG, R. J., & VARNER, A. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1980-02
- Volume
- 50
- Issue
- 2
- Pages
- 251-257
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1967477824
- Cited by
- 300
- References
- 0
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *. https://app.cochat.ai/papers/10.1210/jcem-50-2-251
- The paper
- MORLEY, J. E., BARANETSKY, N. G., WINGERT, T. D., CARLSON, H. E., HERSHMAN, J. M., MELMED, S., LEVIN, S. R., JAMISON, K. R., WEITZMAN, R., CHANG, R. J., & VARNER, A. A. (1980). Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-50-2-251
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.